Internal + Extramural
Please visit our website to find the complete and updated list of cancer-focused extramural funding opportunities or subscribe to UFHCC Opportunity to receive the weekly email.
Special Announcement
UF Health Cancer Center ACS-IRG Pilot Projects (Funded by American Cancer Society Grant #21-139-01-IRG)
Early Stage Investigators Specific
LOI Due (Required): 1/15/2022
Application: 2/15/2022
![AI](https://connection.cancer.ufl.edu/wordpress/files/2021/10/v2-220x147.jpg)
Internal Opportunities
Cancer Artificial Intelligence
Application: 2/28/2022
Utilization of Shared Resources in Cancer Research
Application: 1/31/2022
Limited Opportunities
V Foundation Pediatric V Scholar and Translational Cancer Research Grant
LOI Due: 1/31/2022
Application: 2/15/2022
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 – Independent Basic Experimental Studies with Human Required)
RFA-CA-21-062
LOI Due: 1/9/2022
Application: 2/28/2022
Pediatric Cancer Research Foundation Grants
LOI Due: 2/7/2022
Application: 3/1/2022
Breast Cancer Alliance Exceptional Project Grants
LOI Due: 2/14/2022
Application: 4/1/2022
2023 Pew-Stewart Scholars Program for Cancer Research Award
LOI Due: 4/17/2022
Application: 5/18/2022
External | Non-Limited Opportunities
National Cancer Institute (NCI)
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)
PAR-21-329
Application: 2/5/2022
Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional)
PAR-20-302
Application: 2/5/2022
Modulating Human Microbiome Function to Enhance Immune Responses Againes Cancer (R01 Clinical Trial Optional)
PAR-22-061
Application: 2/5/2022
NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)
PAR-21-306
Application: 2/8/2022
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early
Detection Research (U01 Clinical Trial Not Allowed)
PAR-21-330
Application: 2/11/2022
Tobacco Control Policies to Promote Health Equity (R21 Clinical Trial Optional)
PAR-20-303
Application: 2/16/2022
Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R21 Clinical Trial Not Allowed)
PAR-22-062
Application: 2/16/2022
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
PAR-22-091
Application: 2/16/2022
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
PAR-22-090
Application: 2/16/2022
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
RFA-CA-22-002
Application: 4/22/2022
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
RFA-CA-22-001
Application: 4/22/2022
Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
PAR-21-341
Application: 6/7/2022
National Institutes of Health (NIH)
Notice of Special Interest (NOSI): Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional)
NOT-OD-22-031
Application: 1/31/2022
Measures and Methods to Advance Research on Minority Health and Health Disparities-Related Constructs (R01 Clinical Trial Not Allowed)
PAR-22-072
Application: 2/5/2022
Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 – Clinical Trial Optional)
PAR-20-070
Application: 2/16/2022
New Investigators to Promote Workforce Diversity in Genomics, Bioinformatics, or Bioengineering and Biomedical Imaging Research (R01 Clinical Trial Optional)
RFA-HG-21-041
Application: 2/22/2022
Discovery of Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)
PAR-22-054
Application: 2/28/2022
Research to Improve Native American Health (R21 Clinical Trials Optional)
PAR-20-2014
Application: 5/17/2022
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
PAR-20-238
Application: 5/17/2022
External | Non-Peer Reviewed Agencies
Leukemia Research Foundation
Leukemia Research Foundation Grant
Application: 2/4/2022
American Association for Cancer Research
Gertrude B. Elion Cancer Research Award
Application: 1/31/2022
Jane Coffin Child Memorial Fund
Postdoctoral Fellowships in Cancer Research
Application: 2/1/2022
L’Oreal Groupe
The L’Oreal USA for Women in Science Fellowship
Application: 1/28/2022
Sarcoma Foundation of America
2022 Funding Opportunity Announcement
Application: 2/1/2022
Alex’s Lemonade Stand Foundation
2022 Pediatric Oncology Student Training Program
Application: 2/21/2022
Florida Breast Cancer Foundation
FBCF: Education Grants
Application: 3/11/2022
Bladder Cancer Advocacy Network
2022 Patient-Centered Clinical Research Young Investigator Award
Application: 2/22/2022
Young Investigator Award 2022
Application: 2/22/2022
GMaP Region 2
2022 Footsteps to Funding Targeted Training Workshop Application
Application: 2/18/2022
Cancer Research Institute
Irvington Postdoctoral Fellowship Program
Application: 3/1/2022